Benign Prostatic Hyperplasia
📧 Sign up to get email alerts when something new happens for Benign Prostatic Hyperplasia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-09-19Clinical Trial Update: Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic Hyperplasia [Phase 4]
The Phase 4 study evaluating symptomatic relief with FLOMAX (tamsulosin) in benign prostatic hyperplasia has completed.
-
CLINICAL_TRIALS research · 2014-09-19Clinical Trial Update: Observational Study in Patients Suffering From Benign Prostatic Hyperplasia Treated With Alpha-adrenergic Blockade
This clinical trial update describes an observational study in patients with benign prostatic hyperplasia treated with alpha-adrenergic bloc…
-
CLINICAL_TRIALS trial_result · 2014-09-19Clinical Trial Update: Efficacy, Tolerability and Safety of ALNA® in Patients With Benign Prostatic Syndrome (BPS)
This clinical trial update evaluates the efficacy, tolerability, and safety of ALNA in patients with Benign Prostatic Hyperplasia. The trial…
-
CLINICAL_TRIALS trial_result · 2014-09-19Clinical Trial Update: Study to Characterise the Effect of Tamsulosin on Lower Urinary Tract Symptoms (LUTS) and Detrusor Motor Activity in Patients Affected by Benign Prostatic Hyperplasia (BPH) and Storage Urinary Symptoms [Phase 4]
Phase 4 clinical trial update evaluating the effect of tamsulosin on lower urinary tract symptoms and detrusor activity in men with benign p…
-
CLINICAL_TRIALS trial_result · 2014-09-19Clinical Trial Update: Observational Study of ALNA® (Tamsulosin) in Patients With Benign Prostatic Hyperplasia (BPH)
An observational study of ALNA (tamsulosin) in benign prostatic hyperplasia has completed. The snippet provides the completion status but no…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-09-19Clinical Trial Update: Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia
An observational study evaluating tamsulosin in patients with benign prostatic hyperplasia has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-18Clinical Trial Update: Impact of Bladder Underactivity on Treatment Outcomes of Laser Prostatectomy
This clinical trial update examines how bladder underactivity may affect outcomes after laser prostatectomy in men with benign prostatic hyp…
-
CLINICAL_TRIALS research · 2014-09-17Clinical Trial Update: Predictors of de Novo Urge Urinary Incontinence After Photoselective Vaporization of the Prostate
A clinical trial update examining factors that predict de novo urge urinary incontinence after photoselective vaporization of the prostate.
-
CLINICAL_TRIALS trial_result · 2014-09-16Clinical Trial Update: Impact of Postoperative Pyuria on Treatment Outcomes After PVP
A clinical trial update assessing whether postoperative pyuria influences treatment outcomes after photoselective vaporization of the prosta…
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and Tamsulosin [Phase 1]
Phase 1 study evaluating pharmacokinetic interaction between tadalafil and tamsulosin; the trial has completed. Sponsor: Hanmi Pharmaceutica…
-
CLINICAL_TRIALS trial_result · 2014-08-29Clinical Trial Update: Prostate Cancer Antigen 3 (PCA-3) Gene Project [NA]
Clinical trial update notes a completed study involving the PCA-3 gene project related to prostate cancer and benign prostatic hyperplasia. …
-
CLINICAL_TRIALS trial_result · 2014-08-26Clinical Trial Update: Holmium Laser Enucleation of Prostate(HOLEP) vs Greenlight(XPS) Laser Photoselective Vapo-Enucleation of Prostate(PVEP) [Phase 4]
A Phase 4 clinical trial comparing Holmium laser enucleation of the prostate (HOLEP) with GreenLight PVEP for benign prostatic hyperplasia h…
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH [Phase 2]
Phase 2 trial results evaluating the combination of tamsulosin hydrochloride and solifenacin succinate in men with lower urinary tract sympt…
-
FDA approval · 2014-07-28FDA Approved: DOXAZOSIN — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for doxazosin from Mylan Pharmaceuticals Inc., signaling a regulatory action that likely updates lab…
-
FDA approval · 2014-07-28FDA Approved: CARDURA XL — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Cardura XL (doxazosin mesylate) submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2014-07-28Clinical Trial Update: Effective Dose of Dexmedetomidine for Sedation in Patients Undergoing TURP/TURB Under Spinal Anesthesia With or Without Fentanyl by Age Groups: Randomized Comparative Study [NA]
A randomized comparative study evaluated the effective dose of Dexmedetomidine for sedation in patients undergoing TURP/TURB under spinal an…
-
CLINICAL_TRIALS trial_result · 2014-07-28Clinical Trial Update: Drug Use Investigation for AVOLVE(BPH)
Clinical trial update indicating completion of a Drug Use Investigation for AVOLVE in benign prostatic hyperplasia.
-
CLINICAL_TRIALS trial_result · 2014-07-28Clinical Trial Update: The Effective Concentration of Lidocaine With Fentanyl in Lumbar Epidural Anesthesia for Transurethral Resection of Prostate(TURP) in Elderly Patients [NA]
Study investigating the effective concentration of lidocaine with fentanyl in lumbar epidural anesthesia for TURP in elderly patients with b…
-
CLINICAL_TRIALS trial_result · 2014-06-30Clinical Trial Update: Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels [Phase 2]
Phase 2 trial update reporting that a cyclooxygenase-2 inhibitor reduced serum PSA levels in benign prostatic hyperplasia.
-
CLINICAL_TRIALS trial_result · 2014-06-16Clinical Trial Update: Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate Enlargement [Phase 4]
Phase 4 trial comparing dutasteride plus tamsulosin with lifestyle advice versus watchful waiting with lifestyle advice for treatment-naïve …
-
FDA approval · 2014-06-11FDA Approved: DOXAZOSIN — Original Application (Accord Healthcare Inc.)
FDA approval of Accord Healthcare Inc.'s original application for generic doxazosin (DOXAZOSIN), an alpha-1 blocker indicated for hypertensi…
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) Patients [Phase 4]
This Phase 4 clinical trial update reports on the potential benefits of alpha-blocker monotherapy for lower urinary tract symptoms in men wi…
-
CLINICAL_TRIALS trial_result · 2014-04-30Clinical Trial Update: Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) [Phase 3]
A Phase 3 clinical trial evaluating NX-1207 for benign prostatic hyperplasia has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-30Clinical Trial Update: Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) [Phase 3]
The document reports the completion of a Phase 3 trial evaluating re-injection of NX-1207 for benign prostatic hyperplasia (BPH). The study …
-
CLINICAL_TRIALS trial_result · 2014-04-29Clinical Trial Update: Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia [Phase 4]
A Phase 4 trial evaluated the effectiveness and safety of silodosin for benign prostatic hyperplasia and has completed.